Research on this compound is still developing, and its use is intended for general wellness support, not medical or therapeutic purposes
This ensures immediate bioavailability, especially for patients with absorption issues such as gut inflammation, low stomach acid, or conditions like pernicious anemia
759 Mutation of this Cys to Ala or Ser largely inactivates the enzyme, which suggests that S -nitrosation may be a protective mechanism that preserves FolEIB activity under conditions of nitrosative stress
Cell 161 , 161172 (2015)
Chemical Information Purity 99%+ HPLC Verified Form Factor Capsules Synonyms Blend Components BPC-157 500 mg CAS: 137525-51-0 TB-500 500 mcg (60 ct) CAS: 77591-33-4 BPC-157 CAS 137525-51-0 Formula C 62 H 98 N 16 O 22 Molar Mass 1419.5347 g/mol TB-500 CAS 77591-33-4 Formula C 212 H 350 N 56 O 78 S Molar Mass 4963.4421 g/mol Research Applications Enteral Combination-Delivery Research: This dual-peptide formulation is investigated in experimental gastrointestinal models to characterize peptide stability, mucosal transport, and bioavailability
This makes it a complementary research compound to IGF-1 receptor studies